Lyrigabalin Capsule 150mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Korea Sintex Pharmaceutical Co., Ltd.
MFDS item code 201906910 · Approved 2019.09.30
This product's status changed to Expired on 2024.09.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of neuropathic pain and fibromyalgia, and adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adult patients. It is also utilized as an adjunct in controlling partial seizures in patients with epilepsy, and is effective even in cases accompanied by secondary generalized symptoms. Additionally, it helps alleviate symptoms of chronic pain syndromes such as fibromyalgia. It is widely used for various neurological disorders and pain issues.
Administer the total daily dose of this medicine, as pregabalin, orally in 2 divided doses, with or without food. Because this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be started at a dose of 150 mg daily. Depending on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 2) Central neuropathic pain Adults: This medicine may be started at a dose of 150 mg daily. Depending on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. After an additional 1 week, it may be increased to the target dose of 600 mg daily. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: This medicine may be started at a dose of 150 mg daily. Depending on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg daily. Start with 75 mg twice daily (150 mg daily); based on efficacy and tolerability, the dose may be increased within 1 week to 150 mg twice daily (300 mg daily). For patients who do not experience sufficient benefit at a dose of 300 mg daily, the dose may be increased within 1 week to 225 mg twice daily (450 mg daily). Clinical studies have also been conducted at a dose of 600 mg daily, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg daily are not recommended. 4. Discontinuation Based on current clinical experience, if this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted unchanged by the kidneys. Its clearance is directly affected by creatinine clearance; therefore, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result obtained from the above formula by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients receiving hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose determined according to renal function, an immediate supplemental dose should be administered after every 4 hours of hemodialysis. [Table 1]. Pregabalin dose based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Administration method Starting dose (mg/day) Maximum dose (mg/day) ≥60 | 150 | 600 | BID or TID ≥30 -<60 | 75 | 300 | BID or TID ≥15 -<30 | 25-50 | 150 | QD or BID <15 | 25 | 75 | QD Supplemental dose after hemodialysis | 25 | 100 | Single dose b TID = Total daily dose divided into 3 doses BID = Total daily dose divided into 2 doses QD = Administered once daily a: The total daily dose (mg/day) should be divided as specified under administration method. b: The supplemental dose is an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (aged 65 years or older) Dose reduction may be necessary in elderly patients with impaired renal function.
7. Pediatric and adolescent patients Administration is not recommended in children under 12 years of age or adolescent patients aged 12 ~17 years because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression appear during treatment, you should inform your healthcare provider immediately. Patients with allergies to this medication or specific hereditary conditions like lactose intolerance should not take it. Diabetes patients should be cautious as weight gain may require adjustments in blood sugar control medications. If severe allergic reactions such as angioedema occur, discontinue the medication immediately and consult a healthcare professional. Elderly patients should be particularly careful during the initiation phase of treatment due to the risk of dizziness or drowsiness, which may lead to falls or injuries. Blurred vision or changes in sight may occur; discontinue the medication if these symptoms appear. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered gradually after consulting with a healthcare provider. Due to the potential for misuse, caution is required for patients with a history of substance abuse. Patients with renal impairment may need dosage adjustments. Patients with severe heart disease should be careful when taking this medication. Caution is also advised when taking this medication with opioid analgesics, as the central nervous system depressant effects may be amplified. Patients with respiratory or neurological diseases, elderly patients, and those with renal impairment may be at increased risk for severe respiratory depression, so dosage adjustments may be necessary. During early pregnancy, there is a risk of fetal malformation, so women who are pregnant or planning to become pregnant should consult their healthcare provider before taking this medication and employ effective contraception methods. Breastfeeding women should consult with their healthcare provider regarding the use of this medication, as it can be passed to the baby through breast milk, potentially affecting the infant. Dizziness or drowsiness may occur when performing hazardous tasks such as driving or operating machinery, so caution is advised. If severe rashes, swelling, or respiratory difficulties occur, discontinue the medication immediately and notify a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, depression, or seizures may occur, and immediate emergency treatment is required. Keep this medication out of the reach of children and do not transfer it to other containers.
Suicidal thoughts, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, periorbital edema, upper respiratory tract edema, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, depression, pain, sweating, vertigo, rhinitis, neutropenia, increased appetite, loss of appetite, hypoglycemia, confusion, disorientation, irritability, euphoria, decreased libido, depersonalization, hyperesthesia, restlessness, mood swings, emotional blunting, emotional elevation, difficulty finding appropriate terms, hallucinations, abnormal dreams, increased libido, panic attacks, inability to restrain oneself, apathy, ataxia, motor coordination abnormalities, balance disorders, amnesia, attention disorders, memory impairment, tremors, dysarthria, sensory abnormalities, sensory deficits, sedation, somnolence, cognitive impairment, nystagmus, speech disorders, myoclonus, decreased reflexes, motor abnormalities, psychomotor agitation, position-related dizziness, hypersensitivity, burning sensation, action tremors, syncope, confusion, hypokinesia, olfactory abnormalities, loss of taste, writing disorders, diplopia, indirect vision loss, visual disturbances, visual field defects, photophobia, dry eyes, ocular swelling, decreased vision, eye pain, eye fatigue, increased tear production, ocular irritation, mydriasis, changes in depth perception during vibration, strabismus, brightness of the visual field, vertigo, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, pharyngeal tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, excessive salivation, gastroesophageal reflux, oral sensory loss, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweat, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasm, neck pain, muscle rigidity, rhabdomyolysis, urinary disturbances, incontinence, reduced urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, breast pain, nipple discharge, breast enlargement, peripheral edema, swelling, gait disturbances, falls, feeling drunk, sensory disturbances, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, elevated serum creatine phosphokinase, increased aspartate aminotransferase, increased blood glucose, decreased platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, congestive heart failure, pulmonary edema, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis, affective disorder, confused state, agitation, seizures, drowsiness, sleep disorders, gastrointestinal disorders, bloody stools, increased BUN, urinary retention, tinnitus, skin diseases
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also recommended to store it at room temperature between 15 and 30 degrees Celsius. This helps to maintain the effectiveness of the medication for a longer period.
A hard capsule with a white or slightly yellow powder inside, with a white upper and lower shell.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 150mg
Hard capsule · Prescription medication
Korea Sintex Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.